The Meteoric Rise of GLP-1 Utilization The impact of GLP-1s on Medicare spending is already remarkable
PMID: 33060564
Normally, when you eat, GLP-1 is released naturally and has the following actions: Signals the stomach to release food slowly Stimulates the pancreas to stop releasing glucagon, and start releasing insulin to prepare for a spike in blood sugar (Eventually) travels to the brain and acts on several areas involved in appetite regulation, shutting down the desire for food These are powerful effects, but they are tempered by the fact that GLP-1 doesnt stick around for very long
5- other GLP-1 trials in Parkinsons have been statistically negative or the results unclear, 6- the study was conducted in only very early Parkinsons cases, 7- the data, if replicable, may not be generalizable to all GLP-1 agonist drugs or to all subtypes of Parkinsons, and 8- the drug Lixisenatide requires a DAILY injection
Panonnummal R, Jayakumar R, Anjaneyan G, Sabitha M
An LED device, priced modestly at $69 per treatment, can bring in an annual estimate of around $35,000 with just two treatments a day